POC Infectious Disease Diagnostics Market

POC Infectious Disease Diagnostics Market Size, Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized
laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of
labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests
are comparatively easy to perform and can be performed with minimum amount of training. Infectious
diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging
economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very
frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December
and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017,
wherein point of care diagnostics could be helpful.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/63
Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product
portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the
growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-ofcare diagnostics for infectious diseases, wide applications in remote locations, constant disease
outbreaks, and government funding for product development and research is expected to fuel growth
of the market. The market is expected to gain significant growth, owing to increasing adoption of
point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising
prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to
inventory issues and improper management, and result reliability issues are expected to hinder the
market growth.
Advances in technology of point of care diagnostics is expected to support the growth
of the point of care infectious disease diagnostics market
Centralized laboratory testing is the gold standard and has established in biochemistry,
hematology, and diagnostics. Point-of-care diagnostic offers various advantages such as ease of
use in remote areas, technological advancements, and lowered price points. Small handheld
point-of-care devices are portable and can be used by patients themselves. These tests use
fingerstick or capillary samples, which are directly applied to instrument and avoid need of
sample containers. Technologies such as lateral flow, various molecular assays integrated with
point-of-care have changed the outlook of point-of-care diagnostics. For instance, products
offered by leading manufacturers such as Alere and Roche are immunoassays, which are costeffective and provide rapid results. Furthermore, in 2014, Becton, Dickinson, and Company
offered point-of-care system BD FACSPresto for HIV/AIDS. It offers percentage results of CD4 T
lymphocytes and hemoglobin concentration. Moreover, Infectious Disease Research Institute
(IDRI) developed a fusion antigen in January 2017, which is used as a part of diagnostic test
manufactured by InBios International, Inc. for Chagas disease.
Report includes chapters which deeply display the following deliverable about industry :
• POC Infectious Disease Diagnostics Market Research Objective and Assumption
• POC Infectious Disease Diagnostics Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• POC Infectious Disease Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global POC Infectious Disease Diagnostics Market, By Regions
• POC Infectious Disease Diagnostics Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• POC Infectious Disease Diagnostics Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• POC Infectious Disease Diagnostics Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• POC Infectious Disease Diagnostics Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Major players operating in the point of care infectious disease diagnostics market
include Danaher Corporation, Abbott Laboratories, Alcon Laboratories, Inc., HoffmanLa Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co.,
Ltd. and Cardinal Health, Inc.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/63
Detailed Segmentation:
• Global Point of Care Infectious Disease Diagnostics
• Lateral Flow
• Agglutination Assays
• Flow-Through
• Solid Phase
• Global Point of Care Infectious Disease Diagnostics
• HIV
• Tropical Disease
• Liver Disease
• Inflammatory Disease
• Respiratory Disease
• Hospital Associated Infections (HAIs)
• Sexual Health Disorders
• Others
• Global Point of Care Infectious Disease Diagnostics
• Hospitals
• Diagnostic Laboratories
• Home-Care Settings
• Others
• Global Point of Care Infectious Disease Diagnostics
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
Market, By Technology:
Market, By Application:
Market, By End User:
Market, By Geography:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com